Beta-Thalassemia Completed Phase 2 Trials for Erythropoietin (DB00016)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006136Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia IntermediaTreatment